In DKD patients, adiponectin showed a renoprotective function, translated in a reduction of albuminuria, glomerular hypertrophy, foot process effacement, regulation of mammalian target of rapamycin (mTOR) pathway, kidney inflammation mediators and modulates angiotensin II effects at renal tubular level [105,106]. Here, MTOR is linked to diabetic kidney disease.